NASD Nigeria Appoints Arese Ugwu Acting MD: Past SEC Suspension Noted

• Arese Ugwu has been appointed as the acting Managing Director of NASD, Nigeria's OTC securities exchange.
• This appointment takes place nine years after a regulatory suspension involving Partnership Investment Company, where Ms. Ugwu served as a director.
• Partnership Investment Company was suspended by the Securities and Exchange Commission for a period of five years in the capital market.
• The leadership change at NASD highlights ongoing discussions around corporate governance and regulatory rehabilitation within the Nigerian capital market.

The appointment of an individual with a past regulatory suspension to a key leadership role within a regulated entity like NASD could prompt heightened scrutiny of corporate governance practices and regulatory rehabilitation processes in the Nigerian capital market.

The NASD, Nigeria's over-the-counter (OTC) securities exchange, has announced the appointment of Arese Ugwu as its acting Managing Director. This significant leadership change places Ms. Ugwu at the helm of a key institution within the Nigerian capital market, overseeing its operations and strategic direction.

Her appointment comes at a notable juncture, occurring nine years after a significant regulatory action involving a company where she previously held a directorship. This timing adds a layer of context to the NASD Nigeria leadership change, drawing attention to past regulatory events within the market.

Prior to her current role, Ms. Ugwu served as a director at Partnership Investment Company. This entity faced a substantial regulatory sanction from the Securities and Exchange Commission (SEC), resulting in its suspension from the capital market for a period of five years. The suspension of Partnership Investment Company was a notable event in the Nigerian financial landscape.

Ms. Ugwu was among the board members of Partnership Investment Company during the period leading up to and including its suspension. The five-year ban imposed on the company by the SEC underscored the regulatory body's commitment to market integrity and compliance, impacting all associated directors at the time.

The appointment of Arese Ugwu as acting MD of NASD Nigeria, particularly given her past association with a company that underwent a five-year SEC suspension, carries important implications for the Nigerian capital market appointments and corporate governance standards. Lawyers and compliance officers should take note of this development, as it may prompt a closer examination of regulatory rehabilitation processes and the criteria for leadership roles in regulated entities.

The appointment of an individual with a past regulatory suspension to a key leadership role within a regulated entity like NASD could prompt heightened scrutiny of corporate governance practices and regulatory rehabilitation processes in the Nigerian capital market. This situation may influence the due diligence requirements for future appointments in similar capacities, emphasizing the need for transparency and robust oversight in the NASD OTC market leadership and beyond.

Lawyers and compliance officers should note the appointment of an individual with a past SEC suspension to a key leadership role in a regulated entity, which may prompt scrutiny of corporate governance practices and regulatory rehabilitation processes within the Nigerian capital market, potentially influencing due diligence requirements for similar appointments.

Source: Original reporting via Premium Times Nigeria